Introduction {#s1}
============

Yellow Fever (YF) is a vaccine preventable, zoonotic, arbovirus endemic in tropical regions of Africa and Latin America. It is responsible for approximately 78,000 deaths per year, although under reporting is high and since YF has a non-specific symptom set, misdiagnosis is an issue ([@bib15]). YF has three transmission 'cycles' in Africa: urban, zoonotic and intermediate. The urban cycle, mediated by *Aedes Aegypti* mosquitoes, is responsible for explosive outbreaks such as the one seen in Angola in 2016 ([@bib27]; [@bib67]).

While the urban cycle can rapidly amplify transmission, the majority of YF infections are thought to occur as a result of zoonotic spillover from the sylvatic reservoir in non-human primates (NHP). This zoonotic cycle is mediated by a variety of mosquito vectors including *Aedes africanus* and, as the NHP hosts are mostly unaffected by the infection in Africa, the force of infection due to spillover is fairly constant, although land use change has been shown to affect this ([@bib41]). The intermediate cycle is sometimes called the savannah cycle and is mediated by mosquitoes such as *Ae. luteocephalus*, who feed opportunistically on humans and NHP, although human-human transmission is limited ([@bib2]).

The Intergovernmental Panel on Climate Change (IPCC) states that global mean temperatures are likely to rise by 1.5°C, compared with pre-industrial levels, by between 2030 and 2052 if current trends continue ([@bib37]). Increases are projected not only in mean temperature but also in the extremes of temperature, extremes of precipitation and the probability of drought ([@bib32]; [@bib10]).

With multiple mosquito vectors and a zoonotic cycle depending on NHP hosts, the impact of climate change on YF is likely to be complex. Focusing on the main urban vector, *A. aegypti*, there is strong evidence that projected climate change will alter its global distribution and thus, the risk of diseases it carries ([@bib53]; [@bib71]; [@bib71]). Climate change has been predicted to increase the regions at risk from dengue and Zika transmission, although seasonal variation in temperature may mitigate the likelihood of outbreaks in areas at the edges of the endemic zone ([@bib43]; [@bib26]).

Long-term projections of the future disease burden of YF are needed to inform vaccination planning ([@bib64]). Furthermore, differences due to climate change may increase the risk of epidemics, a key consideration for the Eliminate YF Epidemics (EYE) strategy ([@bib74]).

In this manuscript, we extend an existing model of YF occurrence and disease burden to incorporate a nonlinear temperature suitability metric ([@bib15]). We estimate temperature suitability for YF based on the thermal response of the urban vector, *Ae. aegypti*, and the YF virus. We combine this with YF occurrence data in a Bayesian hierarchical model in order to account for uncertainty at each stage of the modelling process. This, along with established estimates of transmission intensity informed by serological survey data, allow us to predict current and future transmission intensity. Finally, we use ensemble climate model predictions of future temperature and precipitation to project transmission and thus, burden in 2050 and 2070. Our results are the first examination of YF burden under the potential future effect of climate change.

Results {#s2}
=======

As we estimate a static force of infection, we focus on transmission as a result of sylvatic spillover rather than including the urban transmission cycle explicitly. As such, the results can be considered the estimated effect of climate change on sylvatic transmission and resulting burden.

Model predictions for baseline scenario {#s2-1}
---------------------------------------

[Figure 1](#fig1){ref-type="fig"} (left) shows occurrence of YF across Africa from 1984 to 2018. Incidence is focused in the West of Africa and, more recently, Angola and the Democratic Republic of the Congo. The model predicts a high probability of YF report in these areas and reflects the general patterns of YF occurrence, see [Figure 1](#fig1){ref-type="fig"} for comparison. Model fit can be characterised by the Area Under the Curve (AUC) statistic ([@bib25]), which was 0.9004, similar to the original model formulation of [@bib15].

![Observed YF occurrence (left) and median probability of a YF report predicted by the GLM.](elife-55619-fig1){#fig1}

The predicted probability of a YF report is positively informed by temperature suitability with the median posterior predicted distribution shown in [Figure 2](#fig2){ref-type="fig"} (left). This highlights the high suitability of countries such as Nigeria and South Sudan for YF transmission. In contrast, Rwanda, Burundi and areas of Mali and Mauritania have low average temperature suitability. The fit of the thermal response models is shown in [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}--[4](#fig2s4){ref-type="fig"}.

![Median predicted model outputs for baseline scenario.\
(Left) Median posterior predicted temperature suitability for the African endemic region with average temperature. (Right) Median predicted FOI for the African endemic region at baseline.](elife-55619-fig2){#fig2}

Projected transmission intensity {#s2-2}
--------------------------------

[Figure 2](#fig2){ref-type="fig"} (right) shows the median posterior predicted estimates of the force of infection for the baseline/current scenario, a comparison of the force of infection estimated only from serological studies, and those estimated from the GLM is provided in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. When we incorporate the ensemble projections of temperature and precipitation change we see heterogeneous impacts on force of infection. [Figure 3](#fig3){ref-type="fig"} shows the percentage change in median force of infection for the year 2070. Projections for 2050 are shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

![Percentage change in force of infection in 2070.\
Median predicted change in force of infection in the African endemic region in 2070 for the four emission scenarios.](elife-55619-fig3){#fig3}

The posterior distributions of predicted changes in force of infection in different African regions are shown in [Figure 4](#fig4){ref-type="fig"} (region definitions shown in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Projections for individual countries are given in the Appedix. In West Africa, the predicted change is clustered around zero in the majority of scenarios; this is particularly the case for year 2050. However, due to wider uncertainty in 2070 and for RCP scenario 8.5 in general, there is a more discernible increase. In the East and Central regions, a predicted increase in force of infection is more apparent. Whilst the differences between 2050 and 2070 are difficult to see for RCP scenario 2.6, both peak above zero. In RCP scenarios 4.5, 6.0 and 8.5, the distinction between years is clear, particularly in 8.5, with the greatest increases seen in 2070 as temperatures are expected to continue to rise.

![Posterior distribution of the change in the spatial mean force of infection (%) for each region of Africa, year and climate scenario.](elife-55619-fig4){#fig4}

When we examine the changes at country level, shown in the appendix, the changes are more heterogeneous. For RCP 2.6 Guinea Bissau, the change in force of infection in 2070 is potentially broad, with a credible interval spanning zero: 10.3% (95%CrI \[−33.2% , 96.3%\]). Whereas in Central African Republic, there is a notable increase by 87.1% (95%CrI \[12.4% , 390.2%\]).

Projected burden {#s2-3}
----------------

The projected percentage change in the annual number of deaths caused by YF across Africa is given in [Table 1](#table1){ref-type="table"}; the projected annual deaths per capita for endemic countries are shown in [Figure 5](#fig5){ref-type="fig"} and in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. These projections assume vaccination is static from 2019 onwards that is that only routine vaccination continues at 2018 levels. Similarly, we assume case management is unvarying. Aggregated numbers of deaths per country and region are shown in the appendix.

###### Predicted percentage change in deaths in the African endemic region in 2050 and 2070 compared to the baseline/current scenario.

  Year   Scenario   95% CrI low   50% CrI low   Median   50% CrI high   95% CrI high
  ------ ---------- ------------- ------------- -------- -------------- --------------
  2050   RCP 2.6    −2.36         4.49          10.84    18.58          37.91
  2050   RCP 4.5    −2.40         7.32          16.71    28.16          57.43
  2050   RCP 6.0    −2.78         6.79          15.49    25.86          51.85
  2050   RCP 8.5    −2.17         11.03         24.92    41.84          88.33
  2070   RCP 2.6    −0.74         4.11          9.99     17.03          34.10
  2070   RCP 4.5    −2.76         7.77          19.28    33.56          71.08
  2070   RCP 6.0    −4.56         8.63          21.35    36.70          77.70
  2070   RCP 8.5    −2.90         16.08         39.57    72.43          178.63

![Posterior predicted annual YF deaths per capita for each country in the African endemic region in 2070.\
Countries are ordered by longitude.](elife-55619-fig5){#fig5}

While lower 95% credible intervals in [Table 1](#table1){ref-type="table"} are negative, the overall posterior probabilities that climate change will increase YF mortality are very high for each climate scenario. The probability that deaths will increase is 95.5% (95% CrI \[95.3%, 95.7%\]) for RCP 2.6 in year 2070, rising to 95.9% (95% CrI \[95.7%, 96.1%\]) for RCP 8.5 in year 2070, values for all scenarios and years are shown in appendix 1.

As with the force of infection projections, the most severe increases are seen for RCP scenario 8.5, especially in year 2070. The distinction between current projected deaths per capita and those under each RCP scenario are most clearly seen for countries in Central Africa, such as Central African Republic, and East Africa, such as Ethiopia. The four countries with the least distinct change, Liberia, Guinea, Sierra Leone and the Gambia, are all in West Africa, commonly thought to see the most intense YF transmission. As such, it appears that the most marked increases in burden are found in East and central Africa.

Discussion {#s3}
==========

We build on an established model of YF occurrence and transmission to accommodate temperature and precipitation projections for four climate emissions scenarios. Non-linear dependence on temperature was incorporated by utilising a function of temperature suitability, informed by thermal response data for *A. aegypti*. We jointly estimated parameters for the temperature suitability and occurrence models in a Bayesian framework, allowing us to quantify the uncertainty in our projections. We found that model fit remained good with a median AUC of 0.9004 despite necessary changes to the covariates used in the occurrence model compared with past work [@bib15]; where changes were required in order to include covariates for which climate change projections were available. This gave us some confidence in the suitability of the model for projecting the impact of climate change on YF transmission through to 2070, the last year for which climate emission scenario projections are available for temperature and precipitation.

The force of infection is projected to increase for the majority of countries in each scenario. Consistently, the Central African Republic is one of the countries most likely to see an increase in transmission, while Liberia and Guinea Bissau have more uncertain projections. This highlights that the most severe proportional increases in force of infection are seen outside West Africa. However, as transmission is currently highest in West Africa, even a small future relative increase of 3% (seen for Liberia in scenario RCP 2.6 in year 2050, see appendix) could equate to a substantial increase in the projected absolute number of annual YF deaths.

In all scenarios, there is a high probability that the number of deaths and deaths per capita will increase in the African endemic region. The most marked changes are seen for RCP 8.5, the most severe emission scenario; however, changes are heterogeneous geographically with large proportional increases occurring in Central and East Africa. We expect the number of deaths per year to increase by 10.0% (95% CrI \[−0.7, 34.1\]) under RCP scenario 2.6 or 40.0% (95% CrI \[−2.9, 178.6\]) under RCP scenario 8.5 by 2070 (see [Table 1](#table1){ref-type="table"} for other values).

We assume that the force of infection changes linearly between 2018 and 2050, and between 2050 and 2070. [Video 1](#video1){ref-type="video"} illustrates this by showing posterior samples of the change in deaths by region for all years between 2018 and 2070. For RCP scenario 2.6, deaths largely cease increasing after year 2050, in line with the assumption that RCP 2.6 represents the situation where contributing carbon activities peak by 2030; however, this scenario has been suggested to be 'unfeasible' ([@bib42]; [@bib61]). In RCP scenario 8.5, carbon contribution activities are assumed to continue increasing throughout the century. A potential impact of this is seen in the number of YF deaths predicted by our model in East and Central Africa, which accelerate after 2050.

###### Percentage change in deaths from 2020 to 2070 in three regions in the African Endemic region under 4 climate change scenarios.

100 samples of the posterior predicted trajectories are shown.

Climate change may affect not only the magnitude of YF disease burden but also its distribution. We find that, through the projected changes in both temperature and rainfall, transmission may change heterogeneously across the region. This is emphasised by their individual contribution; in the appendix, we explore the effects of changes in only temperature or rainfall. This illustrates that whilst temperature change will drive the variation in transmission intensity with rainfall often acting to mitigate, in some countries there can be a 'perfect storm' of altering rainfall and temperature leading to increases in transmission that would not occur if only temperature was varying. This may lead to changing priorities with respect to vaccination. However, it is unclear whether the comparatively low proportional increase in burden seen for West Africa is due to more intensive vaccination or due to the limited increase in force of infection. Our results suggest that there could be drastic proportional increases in burden in East and Central Africa that may lead to greater vaccine demand in areas which have previously been of lower risk. Thus, whilst the countries experiencing the highest numbers of deaths will remain high risk, see [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} for the median distribution of deaths per year, countries such as Ethiopia and Somalia may become higher priority targets for vaccination.

Our analysis has a number of limitations. In order to utilise emission scenario projections, we were limited to covariates with projections in 2050 and 2070, namely temperature and precipitation. This meant that we adapted our previous best-fit model ([@bib15]) to include temperature range, temperature suitability and precipitation rather than enhanced vegetation and landcover. This change slightly reduced fit quality, giving an AUC of 0.9004 as opposed to to 0.9157 ([@bib16]). Vegetation is a key factor determining habitat of non-human primates, an element that may not be captured by the temperature suitability index which focuses on the vector *A. aegypti*. This omission may lead to an overestimation of the future burden as elements such as desertification and the impact of increasing frequencies of forest fires are not considered ([@bib47]; [@bib24]; [@bib28]).

Similarly, whilst the RCP scenarios model socio-economic and land-use changes, we do not explicitly include these aspects here ([@bib62]). As such, we omit the human choices that may affect population distributions and behaviour, for example urbanisation which has been shown to both reduce disease burden ([@bib69]) and increase emergence of arboviruses ([@bib18]; [@bib23]). In the same way, while our model accounts for migration through use of the UN WPP population data, climate scenario-specific migration is not included in the model. This may mean that we under estimate the potential increases in burden due to increased infringing of human environments on the sylvatic cycle. Projecting these non-linear relationships between human behaviour and transmission would be highly uncertain and is a source of ongoing research.

Vaccination is the main control method for yellow fever and whilst we account for vaccine coverage and efficacy in this mansucript, we do not explicitly propagate uncertainty in vaccination coverage. This will be uncertain not only through data scarcity on vaccination campaign doses, wastage and clustering of doses, but also through the uncertainty in demography. We have presented a comparison of scenarios where, in all cases, vaccination coverage distribution, is held to be the same. As such, whilst we focus on the effect of changing transmission, we will underestimate the uncertainty in our estimates of burden in the future.

Data availability constrains aspects of our modelling approach. We use *A. aegypti* and YF-specific datasets to inform the thermal response relationships and thus, temperature suitability index. However, some data, such as information on the extrinsic incubation period are severely limited; we use a dataset of experimental results from 1930s ([@bib6]). These data may be outdated due to current mosquito species potentially adapting to different climates as well as improved experimental procedures. This is a key data gap for YF and new experimental results concerning the extrinsic incubation period could provide valuable insight into the dynamics of the virus in mosquitoes today.

As further experimental data on thermal responses for *A. aegypti* and other vectors of YF become available, the temperature suitability index developed here will be able to be enhanced. YF is known to have multiple vectors, each contributing to transmission cycles differently ([@bib41]), which are likely to have different thermal responses. Focusing only on the urban vector of YF, as we have in this manuscript, means that we will likely under-estimated the uncertainty in the thermal response of the vectors of YF and thus future projections of burden. Additionally, whilst we have included a relatively detailed relationship between transmission and temperature, we have only assumed a simple relationship with rainfall. Currently models of thermal response for vectors of diseases such as YF are well parametrised with experimental results; however, this is not yet the case for the influence of rainfall on transmission although there are clear links with aspects such as vector breeding. As these relationships are better characterised, we can further refine the relationships in the current work to reflect the more nuanced relationships between temperature, rainfall and transmission.

We focus only on a constant force of infection model which is similar to assuming the majority of transmission occurs as a result of zoonotic spillover. This assumption is supported by recent studies [@bib16]; however, the urban transmission cycle, driven by *A. aegypti* plays a crucial role in YF risk and was responsible for recent severe outbreaks such as that in Angola in 2016. Incorporating climate projections into models that examine multiple transmission routes and thermal responses for multiple vectors, would produce a more realistic picture of how the dynamics of this disease may change with climate.

Climate change is projected to have major global impacts on disease distribution and burden ([@bib43]; [@bib26]; [@bib33]). Here, we examined the specific effects on YF and find that disease burden and deaths are likely to increase heterogeneously across Africa. This emphasises the need to implement and prepare for new vaccination activities, and consolidate existing control strategies in order to mitigate the rising risk from YF. Intervention through vaccination is the gold standard for YF, and new approaches are being implemented with respect to fractional dosing which is a useful resort to respond to urban outbreaks in case of vaccine shortage ([@bib63]). Yet, vaccination is not the only potentially effective control for YF, with novel vector control measures such as the use of Wolbachia showing promise, and perspectives to improve clinical management or urban resilience ([@bib51]; [@bib74]). Finally, in order to monitor and respond to changing transmission patterns, effective and sensitive surveillance will be essential.

Materials and methods {#s4}
=====================

A schematic of data sources and models is shown in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.

Datasets {#s4-1}
--------

We use a number of data sets to inform both the generalised linear model (GLM) of YF occurrence and the temperature suitability model. Additionally, we rely on estimates of transmission intensity informed by serological studies which are detailed in [@bib16] and described below.

### YF occurrence {#s4-1-1}

Details of YF outbreaks occurring from 1984 to present day were collated into a database of occurrence, extended from [@bib15]. These data were collected from the World Health Organisation (WHO) weekly epidemiological record (WER), disease outbreak news (DON), published literature and internal WHO reports ([@bib73]; [@bib72]). The database includes all outbreaks recorded for yellow fever and is resolved at province level, any reports that could not be resolved at province level were excluded. Additionally, reports of suspected YF cases were collected in the WHO African Regional Office YF surveillance database (YFSD); this included data from 21 countries in West and Central Africa. The database was based on the broad case definition of fever and jaundice leading to a large proportion of cases attributed to non-YF causes and cross-reactivity with other flaviviruses was not considered. However, the incidence of suspected cases can be used as a measure of surveillance effort and is included as a covariate in the generalised linear model. We assume this to be constant over time due to scarcity of data on the subject.

### YF serological status {#s4-1-2}

Surveys of seroprevalence were conducted in Central and East Africa. We use these to assess transmission intensity in specific regions of the African endemic zone. The current study includes surveys from published sources ([@bib7]; [@bib34]; [@bib40]; [@bib46]; [@bib60]; [@bib65]) and unpublished surveys from East African countries conducted between 2012 and 2015 as part of the YF risk assessment process ([@bib39]). The surveys were included only if they represent the population at steady state, as such outbreak investigations were omitted ([@bib15]). Additionally, in the majority of surveys, vaccinated individuals were not included; however, in South Cameroon, vaccination status is unclear and so we fit an additional vaccine factor for this survey. Summary details of the seroprevalence studies are included in the apendix.

### Past vaccination coverage and demography {#s4-1-3}

Vaccination coverage is estimated using data on historic large-scale mass vaccination activities taking place between 1940 and 1960 ([@bib11]; [@bib44]), routine infant immunisation reported by the WHO and UNICEF estimates of National Immunization Coverage (WUENIC) ([@bib75]), outbreak response campaigns from 1970 onwards which are detailed in the WHO WER and DON ([@bib73]; [@bib72]) and recent preventive mass-vaccination campaigns carried out as part of the yellow fever initiative ([@bib70]). The coverage is estimated with the methodology of Garske et al. and Hamlet et al. and is visualised in the polici shiny application ([@bib15]; [@bib19]). The application provides vaccination coverage estimates at province level for 34 endemic countries in Africa which can be downloaded for years between 1940 and 2050. We assume all targeted age groups have an equal chance of vaccination irrespective of vaccination staus.

Demography is obtained from the UN World Population Prospect (UN WPP) ([@bib9]). We dis-aggregate this to province level by combining it with estimates of spatial population distributions from LandScan 2014 ([@bib8]). This allows us to estimate population sizes at province level for each year of interest assuming that the age structure is relatively similar across all provinces in each country.

### Environmental and climate projections {#s4-1-4}

We use three main environmental covariates within the generalised linear model of YF occurrence: mean annual rainfall, average temperature and temperature range, shown in [Figure 6](#fig6){ref-type="fig"} and listed in [Table 2](#table2){ref-type="table"}. These are gridded data at various resolutions, ranging from approximately 1 km to 10 km, which we average at the first administrative unit level ([@bib45]; [@bib76]; [@bib21]).

###### Generalised linear model covariates.

  Covariate                 Interpretation
  ------------------------- -------------------------------------------------------------
  log(survey quality)       Log of the survey quality for countries in YFSD.
  adm05                     Country factors for countries not in YFSD.
  longitude                 Longitude of province centroid
  temperature suitability   Temperature suitability at average suitability of province.
  temperature range         Temperature range in province.
  rainfall                  Mean Precipitation in province.
  log(pop)                  Log of the human population size of the province

![Spatial data inputs for generalised linear model.\
Countries shown in black are not considered endemic for YF. (**a**) Estimated mean monthly rainfall (mm) for baseline/current scenario. (**b**) Average temperature at baseline/current scenario in °C. (**c**) Longitude. (**d**) Range in temperature at baseline/current scenario in °C.](elife-55619-fig6){#fig6}

Projected temperature and rainfall changes under climate change scenarios were obtained from worldclim version 1.4 ([@bib22]; [@bib12]). These data provided the 5th Intergovernmental panel on climate change (IPPC5) climate projections for four Representative Concentration Pathways (RCPs): 2.6, 4.5, 6.0 and 8.5 ([@bib62]). The different RCPs indicate different possible emission scenarios and represent the resulting radiative forcing in 2100, measured in W/m^2^ or watts per square metre, see [Table 3](#table3){ref-type="table"} for further information ([@bib56]). Each scenario is assumed to peak at a different times, with emissions peaking between 2010 and 2020 for RCP 2.6, but rising throughout the century for RCP 8.5. Projections of the mean global temperature rise by 2046--2065 are 1 or 2 °C for RCPs 2.6 or 8.5, respectively, compared to pre-industrial levels of the 1880s. By the end of the century, these projections suggest a rise of 1 \[0.3 to 1.7\] or 3.9 \[2.6 to 4.8\]°C for RCPs 2.6 or 8.5 ([@bib56]; [@bib52]). Current warming is estimated to be 0.85 °C since pre-industrial levels ([@bib56]). Based on current commitments through aspects such as the Paris agreement, scenarios where temperatures are expected to rise by more than 3 °C have been suggested to be most likely ([@bib54]). As such, a recent study omitted the RCP 2.6 scenario as it is unlikely now to occur ([@bib42]; [@bib61]).

###### Projected change in global mean surface air temperature and CO2 concentrations by 2100 relative to the reference period of 1986--2005 ([@bib56]).

  Scenario   Temperature rise (°C) \[range\]   CO2 concentrations (ppm)
  ---------- --------------------------------- --------------------------
  RCP 2.6    1 \[0.3 to 1.7\]                  421
  RCP 4.5    1.8 \[1.1 to 2.6\]                538
  RCP 6.0    2.2 \[1.4 to 3.1\]                670
  RCP 8.5    3.7 \[2.6 to 4.8\]                936

Projected mean rainfall, maximum temperature and minimum temperature are available for each RCP scenario in years 2050 and 2070. We take the midpoint and range of the temperature as inputs for the model of YF occurrence, where the midpoint temperature is used to calculate the temperature suitability index.

We do not model changes in climate prior to 2018, instead using Worldclim baseline estimates described as representative of conditions from 1960 to 1990 ([@bib22]).

### Temperature suitability {#s4-1-5}

We estimate the components of the temperature suitability index from YF-specific sources of information on extrinsic incubation period, vector mortality and bite rate for *A. aegypti*, the urban vector of YF ([@bib6]; [@bib58]; [@bib20]; [@bib43]). The extrinsic incubation period was estimated from the experimental results of Davis which were calculated specifically for YF in *A. aegypti* ([@bib6]). We included bite rate data from both [@bib43] and [@bib36] which both describe *A. aegypti*. Finally, vector mortality was estimated from the experimental data of [@bib58]. Where data was provided in figure form, plots were digitised to extract the information. All data used for fitting the temperature suitability model are made available in the GitHub repo (<https://github.com/mrc-ide/YF_climateChange>; [@bib17]; copy archived at <https://github.com/elifesciences-publications/YF_climateChange>). Whilst we focus only on thermal response of the urban vector of YF due to data availability, we estimate the thermal response models within a Bayesian hierarchical framework in order to capture some of the uncertainty that we miss from examining one vector species.

Models {#s4-2}
------

We reformulate an established model of YF occurrence to accommodate nonlinear dependence on temperature and rainfall ([@bib15]; [@bib29]; [@bib16]). We couple this with established results from a transmission model of serological status to estimate transmission intensity across the African endemic region at baseline/current environmental conditions . Then, we project transmission intensity for four climate scenarios given projected changes in temperature and rainfall.

### YF occurrence {#s4-2-1}

The generalised linear model (GLM) of YF occurrence provides the probability of a YF report at first administrative unit level for the African endemic region dependent on key climate variables. In order to assess the effect of climate change on YF transmission, we use the same methodology as ([@bib15]; [@bib29]; [@bib16]); and incorporate covariates indicative of climate change that also have projections available in years 2050 and 2070 for different emission scenarios. As such, we omit enhanced vegetation index and land cover from the best fitting model of [@bib15] in favour of the temperature suitability index which depends on the average temperature, the temperature range and average rainfall. Temperature and rainfall are known to have implications on both the vectors of YF and the distribution of the non-human primate reservoir ([@bib49]; [@bib5]). However, the effect of temperature, particularly on vectors, is highly non-linear with increased mortality seen at very low and high temperatures; as such, we include the range in temperature as a covariate of our occurrence model as well as the non-linear temperature suitability index ([@bib43]; [@bib58]). A full listing of covariates used in given in the appendix.

### Temperature suitability {#s4-2-2}

We model suitability of the environment for YF transmission through temperature dependence. It has been shown that the characteristics of the virus and vector change with temperature ([@bib4]; [@bib33]; [@bib43]; [@bib59]). We model this using a function of temperature for the mosquito biting rate, the extrinsic incubation period and mortality rate for the mosquito which we combine to calculate the temperature suitability based on the Ross-MacDonald formula for the basic reproduction number of a mosquito-borne disease ([@bib35]). In the below, we focus on *A. aegypti*.

The functional form used to model temperature suitability varies in the literature. We continue to use a form which can be parameterised solely from data specific to YF ([@bib20]; [@bib14]). However, alternative formulations have been published in the context of other arboviral infections ([@bib43]; [@bib53]; [@bib4]; [@bib3]; [@bib59]).

Each input of the temperature suitability, $z{(T)}$, is modelled as a function of average temperature where the individual thermal response follow the forms of Mordecai et al. The temperature suitability equation is as follows:$${{z{(T)}} = \frac{a{(T)}^{2}{\exp{({- {\mu{(T)}\rho{(T)}}})}}}{\mu{(T)}}},$$where $T$ denotes mean temperature, $\rho$ is the extrinsic incubation period, $a$ is the bite rate and μ is the mosquito mortality rate. The thermal response models for $\rho$, $a$ and μ follow [@bib43] as follows:$$a(T) = a_{c}T(T - a_{T_{0}})(a_{T_{m}} - T)^{0.5},$$$$\rho(T) = 1/\rho_{c}T(T - \rho_{T_{0}})(\rho_{T_{m}} - T)^{0.5},$$$$\mu(T) = 1/( - \mu_{c}(T - \mu_{T_{0}})(\mu_{T_{m}} - T)),$$where the subscripts $T_{0}$ and $T_{m}$ indicate respectively the minimum and maximum values of each variable, and subscript $c$ labels the positive rate constant for each model. The three resulting parameters for each model are estimated by fitting to available experimental data. The mortality rate μ is limited to be positive.

### Mapping probability of occurence to force of infection {#s4-2-3}

We utilise previously estimated models of seroprevalence informed by serological survey data, demography and vaccination coverage information ([@bib15]; [@bib16]). The transmission intensity is assumed to be a static force of infection, akin to the assumption that most YF infections occur as a result of sylvatic spillover ([@bib15]; [@bib16]). The force of infection is assumed to be constant in each province over time and age. As such, we may model the serological status of the population in age group $u$ as the following:$${S{(\lambda,u)}} = {1 - {\left( {1 - \frac{\sum_{a \in u}{{({1 - {\exp{({- {\lambda a}})}}})}p_{a}}}{\sum_{a \in u}p_{a}}} \right)\left( {1 - \frac{\sum_{a \in u}{v_{a}p_{a}}}{\sum_{a \in u}p_{a}}} \right)}}$$where $\lambda$ is the force of infection, $p_{a}$ the population in annual age group $a$ and $v_{a}$ the vaccination coverage in annual age group $a$. This provides us with estimates of force of infection in specific locations where serological surveys are available.

In order to estimate transmission intensity in areas where no serological survey data is available, we link the GLM predictions with seroprevalence estimates through a Poisson reporting process. The force of infection can be used to estimate the number of infections in any year. Thus, we may calculate the number of infections over the observation period. These will be reported with a certain probability to give the occurrence shown in the GLM. As such, we assume that the probability of at least one report in a province over the observation period, $q_{i}$, depends on the number of infections in the following way:$$q_{i} = {1 - {({1 - \rho_{i}})}^{n_{{inf},i}}}$$where $\rho_{c}$ is the per-country reporting factor which we relate to the GLM in the following way:$${n_{{inf},i}{\ln{({1 - \rho_{c}})}}} = {- {\exp{({X\beta})}}}$$where $X$ are the model covariates and $\beta$, the coefficients. The probability of detection can then be written in terms of the country factors, which are GLM covariates, $\beta_{c}$, and $b$, the baseline surveillance quality calculated from the serological survey data:$${{\ln{({- {\ln{({1 - \rho_{c}})}}})}} = {\beta_{c} + b}}.$$

Thus, we may transform the predictions given by the GLM of YF occurrence using the probability of detection obtained in the provinces where we have both serological studies and GLM predictions to produce FOI estimates for the entire endemic region.

Estimation {#s4-3}
----------

We estimate the models of temperature suitability and YF report together within a Bayesian framework using Metropolis-Hastings Markov Chain Monte Carlo sampling with an adaptive proposal distribution ([@bib1]; [@bib38]; [@bib50]; [@bib55]; [@bib57]). The likelihood contains components for the GLM of YF reports as well as the thermal response models and is given by the following:$${{\log{(L)}} = {{\log{(L_{GLM})}} + {\log{(L_{a})}} + {\log{(L_{\rho})}} + {\log{(L_{\mu})}}}},$$where $\log{(L_{x})}$ denotes the log likelihood of element $x$. The log likelihood for the GLM assumes that the binary YF occurrence data is Bernoulli distributed ([@bib15]):$${{\log{(L_{GLM})}} = {\sum\limits_{i}\left( {{y_{i}{\log{(q_{i})}}} + {{({1 - y_{i}})}{\log{({1 - q_{i}})}}}} \right)}},$$where $y_{i}$ is the binary occurrence and $q_{i}$ is the probability of at least one YF report in province $i$. We propagate uncertainty in the estimation of the GLM from the thermal response models as well as that from the seroprevalence into the resulting transmission intensity estimates.

The thermal response likelihoods are provided by an exponential distribution for bite rate, a Bernoulli distribution for mortality and a normal distribution for extrinsic incubation period.

The estimation, analysis and manuscript were all performed or written in R version 3.5.1, ridgeline plots were generated with packages ggplot2 and ggridges ([@bib48]; [@bib66]; [@bib68]; [@bib13]).

Future projections {#s4-4}
------------------

In order to assess future changes in force of infection, and thus disease burden, we incorporate ensemble climate projections of temperature change and precipitation. We assume that the force of infection is constant until 2018 and then changes linearly between 2018, 2050 and 2070, the years for which climate projections are available. Furthermore, in order to compare only the influence of changing population and force of infection, we assume that vaccination after 2019 is kept at the routine levels of 2018. As such, the results will not be affected by country-specific preventive vaccination campaigns but, future burden will be over estimated as there are likely to be preventive and reactive campaigns in future. We estimate burden by calculating the proportion of infections who become severe cases and then, of those, the proportions that die, using published case fatality ratio estimates ([@bib31]). We compare burden estimates with a baseline scenario assuming the same demographic conditions and vaccination levels as the climate change scenarios but no change in climate variables (precipitation and temperature) over time.
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Data availability {#s7}
=================

Public repository data: Vaccination coverage: coverage is available to download from the PoLiCi shiny app : <https://shiny.dide.imperial.ac.uk/polici/>. Serology surveys: There are seven published surveys used, available at DOI:10.1016/0147-9571(90)90521-T, DOI:10.1093/trstmh/tru086, DOI: 10.1186/s12889-018-5726-9, DOI: 10.4269/ajtmh.2006.74.1078, PMID: 3501739, PMID: 4004378, PMID: 3731366 Demographic data: Population level data was obtained from UN WPP <https://population.un.org/wpp/>, this was disaggregated using Landscan 2014 data <https://landscan.ornl.gov/landscan-data-availability>. Environmental data: This was obtained from LP DAAC: <https://lpdaac.usgs.gov/> and worldclim <http://www.worldclim.org/> Yellow fever outbreaks: These were compiled from the WHO weekly epidemiologic record and disease outbreak news <https://www.who.int/wer/en/> and <https://www.who.int/csr/don/en/>. Data elsewhere: The data from the WHO YF surveillance database and from recent serological surveys from WHO member states in Africa underlying the results presented in the study are available from World Health Organization (contact: William Perea, pereaw\@who.int or Laurence Cibrelus, cibrelusl\@who.int or Jennifer Horton, jhorton\@who.int).

Serological surveys {#s8}
===================

The included surveys are the same as described in Gaythorpe, et al. Summary statistics for these surveys are included in the following table [Appendix 1---table 1](#app1table1){ref-type="table"}.

###### Characteristics of included serological surveys. Recreated from [@bib16].

  Location                                   Sample size   Year   Reference
  ------------------------------------------ ------------- ------ -----------
  Nigeria                                    184           1990   [@bib46]
  Democratic Republic of the Congo           140           1985   [@bib65]
  Republic of the Congo                      360           1985   [@bib40]
  Cameroon (North)                           840           1987   [@bib60]
  Cameroon (South)                           256           2001   [@bib34]
  Uganda (zones)                             584           2012   
  Rwanda (zones)                             1286          2012   
  Zambia (zones)                             3679          2013   
  Sudan (zones)                              1814          2012   
  Kenya (zones)                              1960          2013   
  Ethiopia (zones)                           1645          2014   [@bib39]
  Democratic republic of the Congo (zones)   479           2014   
  South Sudan (zones)                        1480          2014   
  Chad (zones)                               352           2014   

###### Parameter estimates with low and high ends of the 95% credible interval.

  Parameter              95% CrI low   Median     95% CrI high   Meaning
  ---------------------- ------------- ---------- -------------- ------------------
  a_c                    0.0002        0.0003     0.0003         Bite rate
  a_T0                   0.2205        2.9285     7.2004         Bite rate
  a_Tm                   40.0223       40.1368    40.2981        Bite rate
  adm05AGO               1.1382        1.7656     2.3960         GLM coefficients
  adm05BDI               −1.1566       −0.3275    0.4671         GLM coefficients
  adm05ERI               −0.9901       −0.1074    0.7519         GLM coefficients
  adm05ETH               −1.2878       −0.5366    0.1882         GLM coefficients
  adm05GNB               −1.4959       −0.7566    −0.0692        GLM coefficients
  adm05KEN               −1.1264       −0.3510    0.3722         GLM coefficients
  adm05MRT               −1.1837       −0.4218    0.2927         GLM coefficients
  adm05RWA               −1.1411       −0.3175    0.4826         GLM coefficients
  adm05SDN               −0.8870       −0.1106    0.6377         GLM coefficients
  adm05SOM               −1.0177       −0.1425    0.7144         GLM coefficients
  adm05SSD               −0.9086       −0.0796    0.7140         GLM coefficients
  adm05TZA               −1.3990       −0.6442    0.0812         GLM coefficients
  adm05UGA               −0.6618       −0.0081    0.6163         GLM coefficients
  adm05ZMB               −1.2049       −0.3840    0.3975         GLM coefficients
  Intercept              −16.4268      −13.2731   −10.2753       GLM coefficients
  log.surv.qual.adm0     0.3209        0.5048     0.6917         GLM coefficients
  logpop                 0.9133        1.1466     1.3913         GLM coefficients
  lon                    −1.1806       −0.9173    −0.6557        GLM coefficients
  mu_c                   −0.8003       −0.7578    −0.7166        Mortality
  mu_T0                  12.2133       12.7137    13.1498        Mortality
  mu_Tm                  38.0341       38.0481    38.0532        Mortality
  iEIP_c                 0.0001        0.0001     0.0002         Inverse EIP
  iEIP_T0                10.9412       17.6724    22.2418        Inverse EIP
  iEIP_Tm                39.0737       42.1075    45.5927        Inverse EIP
  temp_suitability       0.0101        0.1523     0.3863         GLM coefficients
  worldclim_rainfall     0.2338        0.4629     0.6969         GLM coefficients
  worldclim_temp_range   −0.1912       0.0368     0.2687         GLM coefficients

###### Deaths in the African endemic region in 2050 and 2070 compared to the baseline/constant scenario.

  Year   Scenario   Median   95% Cr interval
  ------ ---------- -------- --------------------
  2050   RCP 2.6    191309   \[62462, 468985\]
  2050   RCP 4.5    200470   \[66330, 499615\]
  2050   RCP 6.0    198096   \[65113, 489494\]
  2050   RCP 8.5    214427   \[69699, 554842\]
  2050   baseline   172668   \[58177, 395300\]
  2070   RCP 2.6    273582   \[90275, 653145\]
  2070   RCP 4.5    298822   \[99694, 735109\]
  2070   RCP 6.0    301001   \[99551, 739950\]
  2070   RCP 8.5    349157   \[108913, 933389\]
  2070   baseline   249556   \[84877, 560186\]

###### Probability of increase (%) in deaths in the African endemic region in 2050 and 2070 compared to the baseline/constant scenario.

  Year   Scenario   Median   95% Cr interval
  ------ ---------- -------- ------------------
  2050   RCP 2.6    92.97    \[92.7, 93.23\]
  2050   RCP 4.5    94.85    \[94.61, 95.07\]
  2050   RCP 6.0    94.89    \[94.64, 95.13\]
  2050   RCP 8.5    95.98    \[95.78, 96.17\]
  2070   RCP 2.6    95.47    \[95.24, 95.7\]
  2070   RCP 4.5    94.64    \[94.41, 94.88\]
  2070   RCP 6.0    94.10    \[93.85, 94.35\]
  2070   RCP 8.5    95.94    \[95.72, 96.15\]

Estimation {#s9}
----------

We estimated the components of the model within a Bayesian framework. The posterior distributions of our parameters could not be written in closed form and so we sample using Markov Chain Monte Carlo (MCMC) Materials and methods. We utilise the classical Metropolis-Hasting algorithm for sampling, where the algorithm is well described by Tennant, Mckinley and Recker. Similarly, we sample new parameters in the MCMC according to a multivariate normal distribution which is adapted according to the covariance of the Markov chain .

![Location of serological study sites shown in green.](elife-55619-app1-fig1){#app1fig1}

Convergence of the Markov chains was assessed visually; however, the approximate number of required iterations to achieve a standard degree of accuracy was calculated using the Raftery statistic. Trace plots of all parameters are presented in [Appendix 1---figure 2](#app1fig2){ref-type="fig"}, resulting parameter estimates are given in [Appendix 1---table 2](#app1table2){ref-type="table"}.

![Traceplots for all parameters.](elife-55619-app1-fig2){#app1fig2}

Twenty chains were run for between 150,000 and 260,000 iterations.

Generalised linear model uncertainty {#s10}
------------------------------------

Uncertainty in the predictions of the generalised linear model of yellow fever risk are presented for the baseline/current scenario in [Appendix 1---figure 3](#app1fig3){ref-type="fig"}. In these, 1000 samples of the posterior predictive distribution were taken and the coefficient of variation was calculated. Uncertainty is extensive, most particularly in East and Central Africa where there are fewer reports of yellow fever occurrence. This uncertainty is propagated into the projections of risk and transmission intensity.

![Coefficient of variation (%) for GLM predictions.](elife-55619-app1-fig3){#app1fig3}

![Predicted force of infection change (%) for each country and scenario in 2050.\
Note, countries are ordered by difference and may vary in position. (**a**) RCP 2.6, (**b**) RCP 4.5, (**c**) RCP 6.0, (**d**) RCP 8.5.](elife-55619-app1-fig4){#app1fig4}

![Predicted force of infection change (%) for each country and scenario in 2070.\
Note, countries are ordered by difference and may vary in position. (**a**) RCP 2.6, (**b**) RCP 4.5, (**c**) RCP 6.0, (**d**) RCP 8.5.](elife-55619-app1-fig5){#app1fig5}

Transmission intensity projection uncertainty {#s11}
---------------------------------------------

We include uncertainty by sampling from the collected posterior distributions 1000 times to give the results shown. This includes uncertainty both in estimated parameters and in the estimates of CFR and proportion of infections that as categorised as severe. We do not include the uncertainty in climate change projections of temperature and precipitation, as such, the uncertainty shown is an under-estimate.

The difference between scenarios is calculated between corresponding samples from the posterior predictive distribution. This means that any difference shown between scenarios is only for one parameter set.

The influence of rainfall and/or temperature change on transmission intensity {#s12}
-----------------------------------------------------------------------------

In the following we calculate the mean transmission intensity from the median posterior predicted force of infection for each province under three scenarios:

1.  That both rainfall and tempature change as per climate scenario RCP 8.5,

2.  That only rainfall changes as per climate scenario RCP 8.5; temperature remains at current levels,

3.  That only temeperature changes as per climate scenario RCP 8.5; rainfall remains at current levels.

In [Appendix 1---figure 6](#app1fig6){ref-type="fig"} we find heterogeneous effects by location. In general, transmission is projected to be higher when modelled with both temperature and rainfall change, this is driven by the change in temperature. In some countries such as Cameroon and Congo, including the projected change in rainfall, moderates the influence of changing temperature that is the highest transmission is seen when only temperature changes. In slight contrast, for Uganda and Kenya, the highest transmission is seen when both temperature and rainfall are changing suggesting a 'perfect storm' of climatic change.

![Predicted mean force of infection per country for 2050 and 2070 under 3 modelling scenarios.\
Projections are calculated from the median posterior predicted force of infection per province. All projections assume temperature and/or rainfall changing under RCP 8.5.](elife-55619-app1-fig6){#app1fig6}

[Appendix 1---figure 6](#app1fig6){ref-type="fig"} is included for illustration of the relative effects of changes in rainfall and temperature across the region. In all climate scenarios, both rainfall and temperature are projected to change (see earlier figures) and so for the main text, we include the influence of both for all projections. projected-number-of-deaths.

Projected number of deaths {#s13}
--------------------------

The projected numbers of deaths in the African endemic region for 2050 and 2070 are shown in [Appendix 1---table 3.](#app1table3){ref-type="table"} and the probability of an increase in deaths is shown in [Appendix 1---table 4.](#app1table4){ref-type="table"}
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This is an important piece of work, of both clear public health importance and of scientific interest, that will guide policies and programmes against Yellow Fever across sub-Saharan Africa in the years ahead due to the potential impact of climate change on the intensity and distribution of yellow fever transmission and disease burden there.

**Decision letter after peer review:**

Thank you for submitting your article \"The effect of climate change on Yellow Fever disease burden in Africa\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Eduardo Franco as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers agreed that this is an important piece of work -- of both clear public health importance and of scientific interest -- that will guide policies and programmes against Yellow Fever across sub-Saharan Africa in the years ahead due to the potential impact of climate change on the intensity and distribution of yellow fever transmission and disease burden there.

Essential revisions:

1\) The description of approach would benefit greatly from a relatively simple schematic diagram to make it very clear how the different data (seroprevalence; occurrence etc.) and modelling components (temperature suitability model; seroprevalence/transmission/FOI model; covariate-driven GLM) link together.

2\) Framework for inferring contemporary pattern of transmission and burden

\- The authors should please provide further details on how the YF occurrence database was compiled and contents of the database. For example, what was the inclusion/exclusion criteria for an occurrence? Was potential cross-reactivity with other flaviviruses considered? For data extracted from WERs, DONs and literature -- at the very least a reference list should be provided.

\- Can you present a map showing areas where you infer FOI based on serological surveys and where it is inferred as a function of the GLM \'probability of a report\' estimate.

\- Some more narrative would also be helpful in explaining conceptually how the FOI-to-probability of occurrence component was achieved. It appears that the ingredients you have in each province for which no sero survey exists are (i) the GLM-derived \'probability of \> = 1 case in a given province\'; (ii) population; (iii) an idea of the probability that a case is detected given that it occurs. Your objective is to infer FOI. It is not clear if you do this within your Bayesian inference framework-thereby somehow borrowing strength from those provinces for which you have both sero surveys and GLM estimates, or, if this is essentially an arithmetic transform that converts the GLM output to an FOI estimate. It appears to be the latter-and if so it is then not clear how robust this transform is, how you infer probability of detection etc. Presumably you could also report on the degree of alignment between your GLM outputs and you FOI calculations in provinces that do have sero-surveys, as an indicator of how well this approach will then work in provinces without surveys.

\- On YF burden from zoonotic/intermediate transmission versus urban transmission cycles (\"the transmission intensity is assumed to be a static force of infection, akin to the assumption that most YF infections occur as a result of sylvatic spillover.\" And also in the Discussion.) Instead of only touching on it in the Discussion perhaps it should be highlighted that the estimate of FOI is limited to burden from zoonotic spillover earlier/throughout the manuscript. Consider describing results as estimated effect of climate change on zoonotic/sylvatic YF burden?

\- How appropriate is it to use temperature suitability pertaining only to the urban vector rather than vectors involved in the intermediate and sylvatic transmission cycles. Also, whether occurrences from urban outbreaks should be excluded from the occurrence database?

\- Can you clarify also what is the implication of focusing on *Ae. aegypti* (subsection "Temperature suitability") instead of other vectors?

3\) Framework for inferring contemporary relationship with rainfall and temperature

\- There is a much greater emphasis/level of sophistication around temperature effects than around rainfall. For temperature, the authors recognise the highly non-linear response via a mechanistic model capturing deterministically the temperature effects on different components of the transmission cycle. For rainfall, however, the presumably similarly complex mechanisms of impact on aedes breeding, vector densities, interactions with humans etc., are represented much more crudely via a single covariate in a GLM, with implicit assumptions around linearity. Some justification on this would be useful.

\- While the paper builds on previous work, the very small number of covariates in the GLM is surprising and needs justification in this current paper. Is there no rationale for including, for example, human population density, or metrics of landscape proxies for non-human primate habitats etc?

\- Further, could there be a bit more discussion of the reasonableness and motivation for omitting land cover and vegetation index? This would seem to be important given that at least in Brazil there\'s a very strong effect of proximity to forest?

4\) Framework for inferring impact of changing climate

\- Given it would be straightforward in your current framework, please consider the utility of running projections with *only* the effects of temperature change and *only* the effects of rainfall change? The rationale being that you have differing levels of sophistication in your ability to link these to YF risk; that there are differing levels of certainty in the climate projections for these two aspects; and that you could provide a richer interpretation of their respective contributions to elevated risk.

\- You elude to it in the Discussion, but more consideration of what you do *not* include in your framework is crucial here. Temperature/rainfall changes may exert upward pressure on transmission and burden -- but how does the magnitude of this effect compare to, for example, a modest increase in vaccination coverage, or changes in exposure due to urbanisation or modernisation of housing etc. How might global change impact other components of the transmission cycle such as the col-location of humans an NHP zoonotic reservoir species?

5\) Impact of vaccination

\- It is not clear from this paper or the references precisely what vaccination coverage data was compiled and how it was used in vaccination coverage estimates. The data and methods are not fully described in this paper or the referenced papers. It seems that uncertainty in vaccination coverage estimates was considered in Garske et al., 2014, by exploring alternate vaccination targeting assumptions. For the analysis in this manuscript, it appears that only the scenario where supplemental vaccination campaigns target unvaccinated individuals is considered? Lessler and colleagues (journal.pmed.1001110) have previously described issues with assumptions about vaccination targeting when making coverage estimates. It is currently not clear whether any uncertainties were propagated through the analyses presented in this paper. It is important to explore the possible impact of these (potentially large) uncertainties on the results.

6\) Impact of future population changes

\- Why were demographic conditions held constant? There ought to be projections for future population growth (and ageing?) for these countries that would give a more accurate representation of future disease burden.

\- Possible to forecast total numbers of deaths as well as the country specific ones?
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Author response

> Essential revisions:
>
> 1\) The description of approach would benefit greatly from a relatively simple schematic diagram to make it very clear how the different data (seroprevalence; occurrence etc.) and modelling components (temperature suitability model; seroprevalence/transmission/FOI model; covariate-driven GLM) link together.

Thank you, we have included a schematic of this information (Figure 1---figure supplement 1).

> 2\) Framework for inferring contemporary pattern of transmission and burden
>
> \- The authors should please provide further details on how the YF occurrence database was compiled and contents of the database. For example, what was the inclusion/exclusion criteria for an occurrence? Was potential cross-reactivity with other flaviviruses considered? For data extracted from WERs, DONs and literature -- at the very least a reference list should be provided.

We have included further details in the methodology to expand on how this was collated (section 2.1.1). This database was detailed first in Garske et al., 2013, and has been updated since. Cross reactivity with other flaviviruses was not included.

> \- Can you present a map showing areas where you infer FOI based on serological surveys and where it is inferred as a function of the GLM \'probability of a report\' estimate.

Thank you, a map of serological study locations has been included in the Appendix (Appendix---figure 1).

> \- Some more narrative would also be helpful in explaining conceptually how the FOI-to-probability of occurrence component was achieved. It appears that the ingredients you have in each province for which no sero survey exists are (i) the GLM-derived \'probability of \> = 1 case in a given province\'; (ii) population; (iii) an idea of the probability that a case is detected given that it occurs. Your objective is to infer FOI. It is not clear if you do this within your Bayesian inference framework-thereby somehow borrowing strength from those provinces for which you have both sero surveys and GLM estimates, or, if this is essentially an arithmetic transform that converts the GLM output to an FOI estimate. It appears to be the latter-and if so it is then not clear how robust this transform is, how you infer probability of detection etc. Presumably you could also report on the degree of alignment between your GLM outputs and you FOI calculations in provinces that do have sero-surveys, as an indicator of how well this approach will then work in provinces without surveys.

We have added further description to clarify the transform (subsection "Mapping probability of occurrence to force of infection") and added a comparison in the Appendix for the alignment between the FOI from serology and from the GLM.

> \- On YF burden from zoonotic/intermediate transmission versus urban transmission cycles (\"the transmission intensity is assumed to be a static force of infection, akin to the assumption that most YF infections occur as a result of sylvatic spillover.\" And also in the Discussion.) Instead of only touching on it in the Discussion perhaps it should be highlighted that the estimate of FOI is limited to burden from zoonotic spillover earlier/throughout the manuscript. Consider describing results as estimated effect of climate change on zoonotic/sylvatic YF burden?

Thank you, we have reviewed the text and included a statement at the beginning of the Results section to highlight this.

> \- How appropriate is it to use temperature suitability pertaining only to the urban vector rather than vectors involved in the intermediate and sylvatic transmission cycles. Also, whether occurrences from urban outbreaks should be excluded from the occurrence database?

Urban outbreaks result first from a spillover event and the majority of the outbreaks are considered to be sylvatic in Africa, as such it would not be necessary to exclude further data form the database.

Using information on the urban vector is an approximation made due to data limitations. However, *Aedes aegypti* is well examined and there are studies available investigating the thermal response of them in different contexts. We also fit the temperature dependence in a hierarchical framework in order to capture some of the uncertainty resulting from the lack of sylvatic vector data. We have added further information in the description of data sources and Discussion to describe this limitation.

> \- Can you clarify also what is the implication of focusing on Ae. aegypti (subsection "Temperature suitability") instead of other vectors?

As we focus on one vector rather than the multitude that are related to YF transmission, it is likely that we have underestimated uncertainty in the response of the vector to changes in climate. We have added to the Discussion to highlight this.

> 3\) Framework for inferring contemporary relationship with rainfall and temperature
>
> \- There is a much greater emphasis/level of sophistication around temperature effects than around rainfall. For temperature, the authors recognise the highly non-linear response via a mechanistic model capturing deterministically the temperature effects on different components of the transmission cycle. For rainfall, however, the presumably similarly complex mechanisms of impact on aedes breeding, vector densities, interactions with humans etc., are represented much more crudely via a single covariate in a GLM, with implicit assumptions around linearity. Some justification on this would be useful.

The relationship between the thermal response of vector attributes such as mortality are well characterised in comparison the influence of rainfall. We have added further description on this in the Discussion.

> \- While the paper builds on previous work, the very small number of covariates in the GLM is surprising and needs justification in this current paper. Is there no rationale for including, for example, human population density, or metrics of landscape proxies for non-human primate habitats etc?

We include human population density -- this was accidentally omitted from the table in the Appendix which is now corrected (Appendix ---table 2).

Human population is included and the landcover metrics are omitted due to uncertainties oh how they will be affected by climate change. Similarly, whilst we use projections of human population sizes which include measures of immigration, the distribution of humans and non-human primates are uncertain and are likely to vary in the future and as a product of climate change. We have added to the description of this in the Discussion.

> \- Further, could there be a bit more discussion of the reasonableness and motivation for omitting land cover and vegetation index? This would seem to be important given that at least in Brazil there\'s a very strong effect of proximity to forest?

Thank you. This limitation is detailed in the Discussion. We required a suite of covariates that both reflected the transmission now but also could be parametrised for the 4 climate scenarios. The vegetation index is thus far not included for this reason.

> 4\) Framework for inferring impact of changing climate
>
> -Given it would be straightforward in your current framework, please consider the utility of running projections with only the effects of temperature change and only the effects of rainfall change? The rationale being that you have differing levels of sophistication in your ability to link these to YF risk; that there are differing levels of certainty in the climate projections for these two aspects; and that you could provide a richer interpretation of their respective contributions to elevated risk.

Thank you, this was an interesting point. We have included a further subsection, "Environmental and climate projections", where we show the change to the mean force of infection per country in 2050 and 2070 given either rainfall *or* temperature changes under climate scenario RCP 8.5. We find that the dominant factor is the change in temperature but that rainfall and temperature change can have interesting effects: in some cases, the change in rainfall mitigates the influence of changing temperature, in others, such as Uganda, the change in both creates a 'perfect storm' where transmission is projected to be highest if both change under the projected scenario.

We have added a further section to the Discussion for this point.

> \- You elude to it in the Discussion, but more consideration of what you do not include in your framework is crucial here. Temperature/rainfall changes may exert upward pressure on transmission and burden -- but how does the magnitude of this effect compare to, for example, a modest increase in vaccination coverage, or changes in exposure due to urbanisation or modernisation of housing etc. How might global change impact other components of the transmission cycle such as the col-location of humans an NHP zoonotic reservoir species?

Thank you, we have expanded the Discussion to further highlight these limitations and that, as this time, projecting these highly non-linear influences may not be possible with available data.

> 5\) Impact of vaccination
>
> \- It is not clear from this paper or the references precisely what vaccination coverage data was compiled and how it was used in vaccination coverage estimates. The data and methods are not fully described in this paper or the referenced papers. It seems that uncertainty in vaccination coverage estimates was considered in Garske et al., 2014, by exploring alternate vaccination targeting assumptions. For the analysis in this manuscript, it appears that only the scenario where supplemental vaccination campaigns target unvaccinated individuals is considered? Lessler and colleagues (journal.pmed.1001110) have previously described issues with assumptions about vaccination targeting when making coverage estimates. It is currently not clear whether any uncertainties were propagated through the analyses presented in this paper. It is important to explore the possible impact of these (potentially large) uncertainties on the results.

We have included further details in how the vaccination coverage was calculated and highlighted the limitations around quantifying uncertainty in vaccination and subsection "Past vaccination coverage and demography", Discussion). We have also emphasised that this is based on methodology that is available in an R package, as a shiny application and has been detailed in both the POLICI application paper \[Hamlet et al., 2019\] including how campaigns are targeted, and in \[Garske et al., 2014\]. In this manuscript, vaccination campaigns are assumed to target people at random rather than only unvaccinated individuals. We also focus on using the same vaccination scenarios in all projections and do not specifically quantify vaccine impact here, although, as noted in the Discussion, it may mitigate some of the effects of changing transmission.

> 6\) Impact of future population changes
>
> \- Why were demographic conditions held constant? There ought to be projections for future population growth (and ageing?) for these countries that would give a more accurate representation of future disease burden.

Demographic conditions are assumed to follow the United Nations World Population Prospects (UNWPP) projections of population growth. As such, demographic conditions are not held constant and future projections of burden take these into account. The counterfactual also assumes population growth.

> \- Possible to forecast total numbers of deaths as well as the country specific ones?

Sure, we have added a table to the Appendix for 2050 and 2070 for all scenarios (Appendix---table 4).
